Health & bio
FDA approves Awiqli, first once-weekly basal insulin
Drugs.com records FDA clearance of insulin icodec (Awiqli) on March 26 as the first once-weekly basal insulin for type 2 diabetes in adults.
Primary sources · 1
Drugs.com records FDA clearance of insulin icodec (Awiqli) on March 26 as the first once-weekly basal insulin for type 2 diabetes in adults.
7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.